Last update 01 Nov 2024
Lexeo Therapeutics, Inc.

Lexeo Therapeutics, Inc.

Startups
|
Public Company|
2018|
New York, United States
|
50-100
| NASDAQ: LXEO|

Overview

Basic Info

Introduction
LEXEO Therapeutics is a comprehensive biotechnology organization. The company's portfolio is largely concentrated on adeno-associated virus (AAV) therapies primarily designed at the Department of Genetic Medicine at Weill Cornell Medicine. In addition to its foremost projects – focusing on both rare and non-rare monogenic (singular gene mutation) disorders – LEXEO Therapeutics' preclinical portfolio extends to monogenic illnesses and hereditary as well as acquired diseases, encompassing different patient population sizes and diverse unaddressed medical needs.

Tags

Cardiovascular Diseases
Nervous System Diseases
Congenital Disorders
AAV based gene therapy
Gene therapy

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
AAV based gene therapy9
Gene therapy2

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
2
6
Preclinical
Phase 2 Clinical
3
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
LX-2020
( plakophilin-2 )
Arrhythmogenic Right Ventricular Dysplasia
More
Phase 2 Clinical
LX-2006
( FXN )
Friedreich Ataxia
More
Phase 2 Clinical
LX-1001
( ApoE2 )
Alzheimer Disease Type 2
More
Phase 2 Clinical
LX-1021
Alzheimer Disease
More
Preclinical
LX-2021
( GJA1 )
Cardiomyopathies
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free